Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CMS Deals Johnson & Johnson’s Chartité Another Reimbursement Setback

This article was originally published in The Gray Sheet

Executive Summary

J&J/DePuy will establish a registry to support reimbursement efforts for the Charité artificial disc after CMS rejected its request for higher payment

You may also be interested in...



CMS New Tech Town Hall: Industry Insists Bonus Threshold Is Too High

Boston Scientific's Wingspan intracranial stent is the only product under consideration for a new technology add-on payment in fiscal year 2008, prompting stakeholders to complain that the opaqueness of CMS' criteria for awarding the bonus payment has deterred most firms from even applying

CMS New Tech Town Hall: Industry Insists Bonus Threshold Is Too High

Boston Scientific's Wingspan intracranial stent is the only product under consideration for a new technology add-on payment in fiscal year 2008, prompting stakeholders to complain that the opaqueness of CMS' criteria for awarding the bonus payment has deterred most firms from even applying

CMS Opens National Coverage Decision Request On Artificial Lumbar Discs

CMS is reviewing whether artificial lumbar discs should be nationally non-covered for Medicare beneficiaries after a physician urged the agency to open a national coverage decision request

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT022482

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel